LatinNews Daily Report - 05 April 2012

Brazil: On 3 April the US aeronautical firm, Boeing, announced that it plans to open an advanced technology research centre, its sixth, in São Paulo, Brazil, later this year. According to a company statement, Boeing Research & Technology-Brazil will work with the country's leading researchers and scientists to develop aerospace technologies, serving as a hub for collaboration between Boeing and Brazilian R&D organizations, including government agencies, private-sector companies and universities. The new research center will focus on sustainable aviation biofuels, advanced air traffic management, advanced metals and bio-materials, and support and services technologies. In July 2011, Boeing and Brazil’s leading aircraft manufacturer, Embraer, announced plans to jointly fund an analysis of opportunities to produce sustainable aviation jet biofuel. In October 2011, Boeing, Embraer and the São Paulo State Research Foundation (FAPESP) signed a letter of intent to expand that analysis and develop a detailed report outlining the opportunities and challenges of creating a cost-effective, bio-derived, and sustainable jet-fuel production and distribution industry in Brazil. Brazil has Latin America's fastest-growing commercial aviation market. According to Boeing, local operators will need to purchase over 1,000 planes worth some US$100bn in the next 20 years. TAM and GOL are Boeing customers. "Boeing is defined by its technological edge, and establishing Boeing Research & Technology in Brazil will bring new ideas and innovative processes to our company," said Donna Hrinak, the president of Boeing Brazil. "We also will strengthen our relationship with Brazil's R&D community in ways that grow Brazil's capabilities and meet the country's goals for economic and technology development."

End of preview - This article contains approximately 1024 words.

Subscribers: Log in now to read the full article

Not a Subscriber?

Choose from one of the following options

• Subscribe
• Sign up for a one-time, 14-day trial